Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma

Treatment with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) has greatly improved clinical outcomes in patients with diffuse large B-cell lymphoma (DLBCL) compared with CHOP. The mechanism of rituximab-induced cell death is poorly understood. We found that rituxi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Zhao, Tiansuo, Ren, He, Wang, Xiuchao, Liu, Pengfei, Yan, Fan, Jiang, Wenna, Li, Yang, Li, Jing, Gribben, John G., Jia, Li, Hao, Jihui
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2015
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695028/
https://ncbi.nlm.nih.gov/pubmed/26315113
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker